View Post

200 Long COVID Symptoms Could Last Years

In COVID-19, Latest News by Precision Vaccinations

Since the COVID-19 pandemic began in late 2019, many people who contracted the SARS-CoV-2 coronavirus have been experiencing symptoms for extended periods, sometimes lasting for months or even years.
According to the Centers for Disease Control and Prevention, about 17% of Americans have experienced Long COVID.
Today, the National Academies of Sciences, Engineering, and Medicine released a new report to clarify which symptoms are associated with a Long COVID diagnosis.

View Post

$603,661 Funds Herpes Monoclonal Antibodies Optimization

In COVID-19, Latest News by Precision Vaccinations

The U.S. National Institute of Allergy and Infectious Diseases (NIAID) has funded a new study led by researchers at the Albert Einstein College of Medicine in New York with $603,661.
Launched on June 1, 2024, the goal of this follow-up project (PA-20-185) is to accelerate the development of strategies to bolster vaccine and monoclonal antibody (mAb) efficacy against a range of pathogens such as herpes simplex virus (HSV).
The total project funding amount for the two projects is now $1,231,761.